Ochsner Health COVID-19 SharePoint Site "Safety On Site" Click here to enter an S.O.S.
Medications listed are available on OH EPIC Formulary, unless otherwise noted.
Not all formulary medications are available at each facility. Please refer to your local pharmacy for available inventory.
Search results for:

cabotegravir-rilpivirine

cabotegravir-rilpivirine
Drug Name Form Strength Infusion Center Available Restricted Non-formulary Ambulatory Available Interchange REMS
Cabenuva 400/600 SUSPENSION, EXTENDED RELEASE, INTRAMUSCULAR 200 mg-300 mg/mL        
VIEW MORE HIV Integrase Inhibitors
CLASS
08180812
Additional Information and Links

Restrictions:

  • Indication:
    • Maintenance treatment of HIV in those who are virologically suppressed (HIV-1 RNA < 50 copies/mL) on a stable antiretroviral regimen and no history of treatment failure
      • Virological suppression for at least 3 months
  • Completed oral lead-in therapy (oral cabotegravir and rilpivirine for ≥ 28 days) with no known or suspected resistance to cabotegravir or rilpivirine
  • Prescribed by an ID provider (preferred) or provider-based IM physicians in BR
    • BR pharmacy will support and manage use in BR
  • Prior authorization
  • Outpatient use, administered in clinics
  • No active or occult HBV infection
  • Not pregnant or not planning to become pregnant
  • Not receiving drugs with significant drug interactions                                                 
Last updated: Jan. 27, 2022

This site is intended for the staff of Ochsner Health. While others may view accessible pages, Ochsner Health makes no warranty, express or implied, as to the use of this information outside of Ochsner Health.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved